Skip to content

Analysis of the stomach microbiota in patients with gastric cancer and gastric polyps

Analysis of the stomach microbiota in patients with gastric cancer and gastric polyps

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12002573
Enrollment
Unknown
Registered
2012-10-16
Start date
2012-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer and Gastric Polyps

Interventions

the gastric cancer group:no intervention
the gastric polyps group:no intervention
healthy control group:no intervention

Sponsors

Department of Gastroenterology and Hepatology, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: In order to be eligible for participation in this study, subjects must meet the following criteria: 1. Male or female subjects 18 years of age, but not more than 60 years of age at the time of enrollment; 2. Subjects of the Han nationality are all from the north areas of China; 3. Must be able to provide signed and dated informed consent; 4. Subjects willing and able to provide biopsies from gastric mucosa; 5. Gastroscopy and histopathology confirm non-cardia gastric cancer or gastric polyps for the first time; 6. Gastroscopy and histopathology confirm the normal gastric mucosa of the healthy subjects at the time of enrollment.

Exclusion criteria

Exclusion criteria: Any subject who meets any of the following criteria will be excluded from participation in this study: 1. Use of any of the following drugs within the last 3 months: (1) systemic antibiotics; (2) corticosteroids; (3) cytokines; (4) methotrexate or immunosuppressive cytotoxic agents; (5) large doses of commercial probiotics consumed; 2. Acute disease at the time of enrollment; 3. Chronic, clinically significant pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality, as determined by medical history or physical examination; 4. Unstable dietary history; 5. Recent history of chronic alcohol consumption and smoking; 6. Positive test for HIV, HBV or HCV; 7. History of major surgery; 8. Female who is pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
phylotype analysis;biodiversity analysis;principal component analysis;

Countries

China

Contacts

Public ContactYang Yunsheng
sunny301ddc@126.com+86 010 55499005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026